The CSIR-Indian Institute of Chemical Technology (CSIR-IICT), Hyderabad, is intensifying efforts to expand the adoption of an indigenous surgical adhesive developed for rapid wound closure and tissue sealing. The technology, based on alkyl 2-cyanoacrylate chemistry, has been designed to provide instant bonding of tissues, even in moist surgical environments.
The innovation represents a significant step toward reducing dependence on imported surgical consumables while offering healthcare providers an alternative solution for selected wound management procedures. The adhesive is biocompatible and can be used for tissue approximation and sealing, potentially minimizing the need for traditional sutures in specific clinical applications.
Industry Collaboration to Expand Market Reach
After successfully transitioning from laboratory research to commercial deployment through a licensing agreement with a pharmaceutical company, CSIR-IICT is now looking to partner with additional industry players. The institute aims to scale production, improve market penetration, and make the technology more widely available across healthcare facilities.
By encouraging broader industry participation, CSIR-IICT seeks to accelerate the commercialization of the product and support the growth of India’s medical technology ecosystem.
Supporting Faster and Efficient Wound Management
One of the key advantages of the adhesive is its ability to create a strong bond within seconds, helping clinicians achieve quicker wound closure. Its effectiveness in moist conditions makes it suitable for surgical settings where conventional closure techniques may be time-consuming or challenging.
The technology may also contribute to improved patient comfort and procedural efficiency by reducing closure time and simplifying post-operative wound management in selected cases.
Boosting Indigenous MedTech Development
The initiative aligns with India’s broader focus on promoting homegrown healthcare innovations and strengthening self-reliance in the medical devices and healthcare technology sectors. Successful commercialization of indigenous solutions such as surgical adhesives can help enhance domestic manufacturing capabilities while creating new opportunities for research-driven healthcare products.
As CSIR-IICT expands industry engagement, the technology is expected to gain wider clinical visibility, paving the way for greater adoption of locally developed innovations in surgical care and wound management.
